Showing results (2071-2080 of 3,086) with videos related to
Sort By:
Pageof 309
Drug Safety|August 29, 2007
Is there still a role for aprotinin in cardiac surgery?Neel R Sodha, Munir Boodhwani, Frank W SellkeDrug Safety|August 29, 2007
Thiazolidinediones and their fluid-related adverse effects: facts, fiction and putative management strategiesJanaka Karalliedde, Robin E BuckinghamDrug Safety|October 9, 2008
Serious adverse reactions of bupropion for smoking cessation: analysis of the French Pharmacovigilance Database from 2001 to 2004Marie-Nöelle Beyens, Claire Guy, Genevieve Mounier, et al.Drug Safety|October 9, 2008
Preventable mix-ups of tuberculin and vaccines: reports to the US Vaccine and Drug Safety Reporting SystemsSoju Chang, Vitali Pool, Kathryn O'Connell, et al.Drug Safety|January 10, 2009
Use and risk management of carvedilol for the treatment of heart failure in the community in England: results from a modified prescription-event monitoring studyBeate Aurich-Barrera, Lynda V Wilton, Saad A W ShakirDrug Safety|November 2, 2007
Benefit-risk assessment of drotrecogin alfa (activated) in the treatment of sepsisDaniel De BackerDrug Safety|August 19, 2008
RevAssist: a comprehensive risk minimization programme for preventing fetal exposure to lenalidomideCarmen P Castaneda, Jerome B Zeldis, John Freeman, et al.Drug Safety|August 19, 2008
Risk of hypospadias in offspring of women using loratadine during pregnancy: a systematic review and meta-analysisEleanor B Schwarz, Myla E Moretti, Smita Nayak, et al.Drug Safety|August 19, 2008
Risk factors associated with adverse drug reactions following hospital admission: a prospective analysis of 907 patients in two German university hospitalsYurdaguel Zopf, Christina Rabe, Antje Neubert, et al.Drug Safety|November 27, 2007
Cardiac repolarisation and drug regulation: assessing cardiac safety 10 years after the CPMP guidanceRashmi R ShahPageof 309